Evaxion Biotech A/S (NASDAQ:EVAX) Upgraded by Zacks Investment Research to Hold

Evaxion Biotech A/S stock has undergone multiple analysts rating changes in the recent past.  Evaxion Biotech A/S Upgraded by Zacks Investment Research on 10/12/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.

Shares of Evaxion Biotech A/S traded up $0.24 on Tuesday, reaching $8.32. 0 shares of the stock traded hands, compared to its average volume of 162993. Shares of Evaxion Biotech A/S were trading at $8.32 on Tuesday. The firm’s 50 day moving average is $7.49 and its 200 day moving average is N/A.Evaxion Biotech A/S has a 12 month low of $8.08 and a 12 month high of $10.34. While on yearly highs and lows, Evaxion Biotech A/S’s today has traded high as $9.25 and has touched $8.08 on the downward trend. See More Analyst Rating at: RATING

Evaxion Biotech A/S Earnings and What to expect: 

Evaxion Biotech A/S last posted its earnings data on August 11th, 2021. The reported ($0.36) EPS for the quarter, missing analysts’ consensus estimates of ($0.29) by $0.07. Evaxion Biotech A/S has generated ($0.97) earnings per share over the last year. Earnings for Evaxion Biotech A/S are expected to decrease in the coming year, from ($1.29) to ($1.90) per share. Evaxion Biotech A/S has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, November 9th, 2021 based off prior year’s report dates.

Earnings for Evaxion Biotech A/S are expected to decrease in the coming year, from ($1.29) to ($1.90) per share. The P/E ratio of Evaxion Biotech A/S is -8.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Evaxion Biotech A/S is -8.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Evaxion Biotech A/S (NASDAQ:EVAX) Moving Average Technical Analysis

5 day Moving Average is $8.44 And 5 day price change is -$0.53 (-5.99%)  with average volume for 5 day average is 15,340. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $8.70 and 20 day price change is $0.72 (9.47%) and average 20 day moving volume is 33,210. 50 day moving average is $7.49  and 50 day price change is $2.52 ( 43.45%)  and with average volume for 50 days is : 104,984. 200 day moving average is N/A  and 200 day price change is N/A (N/A)  and with average volume for 200 days is : N/A.

Other owners latest trading in Evaxion Biotech A/S :

  • On 8/16/2021 shares held by Maven Securities LTD were 235,606 which equates to market value of $1.76M and appx 0.10% owners of Evaxion Biotech A/S
  • On 8/16/2021 shares held by Telemetry Investments L.L.C. were 41,729 which equates to market value of $0.32M and appx 0.40% owners of Evaxion Biotech A/S
  • On 5/18/2021 shares held by Luminus Management LLC were 194,929 which equates to market value of $1.15M and appx 0.20% owners of Evaxion Biotech A/S
  • In total Institutional ownership equates to Institutional Ownership Percentage: 2.29% for Evaxion Biotech A/S

See More Analyst Rating at: RATING